Global profiling of prolactin-modulated transcripts in breast cancer in vivoReport as inadecuate




Global profiling of prolactin-modulated transcripts in breast cancer in vivo - Download this document for free, or read online. Document in PDF available to download.

Molecular Cancer

, 12:59

First Online: 12 June 2013Received: 21 February 2013Accepted: 15 May 2013DOI: 10.1186-1476-4598-12-59

Cite this article as: Sato, T., Tran, T.H., Peck, A.R. et al. Mol Cancer 2013 12: 59. doi:10.1186-1476-4598-12-59

Abstract

BackgroundProlactin PRL is essential for normal mammary gland development. PRL promotes mammary tumor formation in rodents and elevated serum prolactin is associated with increased risk of estrogen-receptor positive breast cancer in women. On the other hand, PRL may also exert pro-differentiation effects and act to suppress invasive features of established breast cancer. Previously published limited global transcript profiling analyses of prolactin-regulated gene expression in human breast cancer cells have exclusively been performed in vitro. The present study aimed to shed new light on how PRL modulates estrogen receptor ER-positive breast cancer through global transcript profiling of a human breast cancer xenograft model in vivo.

MethodsThe prolactin-responsive human T47D breast cancer cell line was xenotransplanted into nude mice and global transcript profiling was carried out following treatment with or without human PRL for 48 h. A subset of PRL-modulated transcripts was further validated using qRT-PCR and immunohistochemistry.

ResultsThe in vivo analyses identified 130 PRL-modulated transcripts, 75 upregulated and 55 downregulated, based on fold change >1.6 and P-value <0.05. From this initial panel of transcripts, a subset of 18 transcripts with established breast cancer-relevance were selected and validated by qRT-PCR. Some but not all of the transcripts were also PRL-modulated in vitro. The selected PRL-modulated transcripts were tested for dependence on Stat5, Jak1 or Jak2 activation, and for co-regulation by 17β-estradiol E2. The protein encoded by one of the PRL-regulated transcripts, PTHrP, was examined in a panel of 92 human breast cancers and found by in situ quantitative immunofluorescence analysis to be highly positively correlated with nuclear localized and tyrosine phosphorylated Stat5. Gene Ontology analysis revealed that PRL-upregulated genes were enriched in pathways involved in differentiation. Finally, a gene signature based on PRL-upregulated genes was associated with prolonged relapse-free and metastasis-free survival in breast cancer patients.

ConclusionsThis global analysis identified and validated a panel of PRL-modulated transcripts in an ER-positive human breast cancer xenotransplant model, which may have value as markers of relapse-free and metastasis-free survival. Gene products identified in the present study may facilitate ongoing deciphering of the pleiotropic effects of PRL on human breast cancer.

KeywordsBreast cancer Prolactin Stat5 Electronic supplementary materialThe online version of this article doi:10.1186-1476-4598-12-59 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: Takahiro Sato - Thai H Tran - Amy R Peck - Chengbao Liu - Adam Ertel - Justin Lin - Lynn M Neilson - Hallgeir Rui

Source: https://link.springer.com/







Related documents